Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 22, Issue 4, Pages 213-225
http://dx.doi.org/10.1155/2006/670439

Comprehensive Phenotyping in Multiple Sclerosis: Discovery Based Proteomics and the Current Understanding of Putative Biomarkers

Kevin C. O’Connor,1 Sushmita Mimi Roy,2 Christopher H. Becker,2 David A. Hafler,1 and Aaron B. Kantor2

1Department of Neurology and the Center for Neurologic Disease, Brigham and Women’s Hospital, Laboratory of Molecular Immunology, Department of Neurology, Harvard Medical School 77 Avenue Louis Pasteur, Boston, MA 02115, USA
2Biomarker Discovery Sciences, PDD, 1505 O’Brien Drive, Menlo Park, CA 94025, USA

Received 10 November 2006; Accepted 10 November 2006

Copyright © 2006 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kevin C. O’Connor, Sushmita Mimi Roy, Christopher H. Becker, David A. Hafler, and Aaron B. Kantor, “Comprehensive Phenotyping in Multiple Sclerosis: Discovery Based Proteomics and the Current Understanding of Putative Biomarkers,” Disease Markers, vol. 22, no. 4, pp. 213-225, 2006. https://doi.org/10.1155/2006/670439.